We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
On June 23, as its 2010 term drew to a close, the U.S. Supreme Court announced its much-awaited decision in Sorrell v. IMS Health Inc. (No. 10-779), holding that Vermont's Act 80, prohibiting access to certain information on physicians' prescribing practices for use in marketing brand-name drugs, violated the First Amendment
